Lind Global Fund II LP 13D/13G Filings for Panbela Therapeutics, Inc. (PBLA)

Lind Global Fund II LP 13D and 13G filings for Panbela Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-01-30
4:38 pm
Purchase
2023-01-3013GPanbela Therapeutics, Inc.
PBLA
Lind Global Fund II LP983
9.900%
983increase
(New Position)
Filing